Entity

Time filter

Source Type

Leverkusen, Germany

Barutzki D.,Veterinary Laboratory Freiburg | Schaper R.,Bayer Animal Health GmbH
Parasitology Research | Year: 2011

In a retrospective study, the results of parasitological examinations of faecal samples from 8,560 cats and 24,677 dogs between January 2003 and December 2010 in Germany were analysed. 30.4 % of the examined dogs and 22.8 % of the cats were infected with endoparasites. The examination of the faecal samples from dogs revealed stages of Giardia spp. (18.6 %), Toxocara canis (6.1 %), Toxascaris leonine (0.6 %), Ancylostomatidae (2.2 %), Trichuris vulpis (1.2 %), Capillaria spp. (1.3 %), Crenosoma vulpis (0.4 %), Angiostrongylus vasorum (0.5 %), Taeniidae (0.4 %), Dipylidiidae (< 0.1 %), Mesocestoides spp. (< 0.1 %), Isospora spp. (5.6 %), I. ohioensis-complex (3.9 %), I. canis (2.4 %), Sarcocystis spp. (2.2 %) and Hammondia heydorni/Neospora caninum (0.3 %). Dogs in the age groups up to 3 months and>3 up to 6 months of age showed significantly higher infection rates with Giardia spp. (37.5 % and 38.2 %, respectively), Toxocara canis (12.0 % and 12.4 %, respectively), Toxascaris leonina (1.1 % and 1.6 %, respectively), Isospora spp. (23.4 % and 11.8 %, respectively), I. ohioensis-complex (15.6 % and 7.2 %, respectively) and I. canis (11.8 % and 5.2 %, respectively) compared to older dogs. In faecal samples from cats, stages of Giardia spp. (12.6 %), Toxocara cati (4.7 %), Toxascaris leonina (0.1 %), Ancylostoma tubaeforme (0.2 %), Aelurostrongylus abstrusus (0.5 %), Capillaria spp. (1.0 %), Taeniidae (0.6 %), Dipylidium caninum (< 0.1 %) Mesocestoides spp. (< 0.1 %), Isospora spp. (6.0 %), I. felis (4.4 %), I. rivolta (2.2 %), Toxoplasma gondii/ Hammondia hammondi (0.8 %) and Sarcocystis spp. (0.3 %) were detected. Cats in the age groups up to 3 months and>3 up to 6 months of age showed significantly higher infection rates with Giardia spp. (19.5 % and 24.0 %, respectively), T. cati (8.1 % and 6.9 %, respectively), Isospora spp. (12.8 % and 8.6 %, respectively), I. felis (10.0 % and 5.9%, respectively) and I. rivolta (4.6 % and 2.9%, respectively) compared to older cats.


The medical as well as the veterinary importance of parasitic arthropods or ectoparasites in general terms, is characterized by the primary or secondary impact on the health of humans and companion animals alike. The parasitic arthropods addressed here are those ectoparasites belong to the class of insects, such as fleas and sand flies, or the subclass of acarids, such as ticks. These parasitic arthropods interact intensively with their hosts by blood feeding. Fleas, sand flies and ticks hold the vector capacity to transmit pathogens such as virus, bacteria or protozoa to cats, dogs and humans. The diseases caused by these pathogens are summarized under the terms canine vector-borne diseases (CVBD), feline vector-borne diseases (FVBD) or metazoonoses. In small animal practice, it is important to understand that the transmitted pathogen may either lead to a disease with clinical signs, or more often to asymptomatic, clinically healthy, or silent infections. Blocking of the vector-host interactions, the blood feeding and subsequently the transmission of pathogens during blood feeding is a key element of CVBD control. The focus of this review is on the current knowledge of the epidemiology of parasitic vectors and three important CVBDs they transmit; rickettsiosis, tick borreliosis and canine leishmaniosis from a European perspective, and how veterinary medicine may contribute to the challenges of CVBDs and their control. Prevention of CVBDs is fundamentally based on ectoparasite control. Ectoparasite management in cats and dogs is important not only for the health and well-being of the individual companion animal but for public health in general and is therefore a perfect example of the 'One health' approach. © 2013.


Barutzki D.,Veterinary Laboratory Freiburg | Schaper R.,Bayer Animal Health GmbH
Parasitology Research | Year: 2013

Infections with the metastrongyloid nematode Aelurostrongylus abstrusus in cats have been reported sporadically from Germany. To assess the occurrence and regional geographical distribution of A. abstrusus in Germany, faecal samples from 391 cats with symptoms of respiratory disease were collected from December 2009 to November 2011. The zinc chloride/sodium chloride flotation and Baermann funnel technique were used to examine the samples for the presence of lungworm larvae. The collected data were analyzed using a geographic information system (GIS). Infections with lungworms were diagnosed in 26 (6.6 %) of the examined cats. The infection rates did not show significant differences in the age groups up to 7 years. Only cats older than 7 were significantly less infected with lungworms than young cats. Sixteen of the 192 female cats examined and 7 of the 186 males were positive for A. abstrusus, but there were no significant differences for the variable 'gender infection rate'. Most of the A. abstrusus-positive cats were located in Baden-Wuerttemberg, followed by Lower Saxony, Bremen, North Rhine-Westphalia, Bavaria, Hesse, Mecklenburg-Western Pomerania, Saarland, Saxony and Schleswig-Holstein. The majority of infected cats showed severe clinical symptoms characterised by coughing and dyspnoea, increased breathing rate, weight loss, bronchopneumonia, generally poor condition, sneezing and nasal discharge. The high number of lungworm-positive cats and the severe clinical symptoms should encourage veterinarians in Germany to consider infections with A. abstrusus as a differential diagnosis in cats with symptoms of respiratory disease. © 2012 The Author(s).


Patent
Bayer Animal Health Gmbh | Date: 2015-02-27

The present invention relates to immunomodulator compositions and methods of use as well as methods of making. The immunomodulator compositions comprise immunostimulatory plasmids, or DNA sequence, capable of eliciting an immune response in a recipient subject. Further, the immunostimulatory plasmids, or DNA sequence, do not contain antibiotic resistance coding sequence to help reduce the potential of horizontal transfer of antibiotic resistance in a population.


Patent
Bayer Animal Health GmbH | Date: 2015-09-22

The invention relates to novel compositions for controlling parasites on animals, comprising an N-arylpyrazole and also a pyrethroid in a formulation comprising aliphatic cyclic carbonates and aliphatic cyclic or acyclic polyethers.

Discover hidden collaborations